Search research articles
Contact Us
Filters
Showing results (91-100 of 130) with videos related to
Page
of 13
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 1997
Multiple system atrophy: a review of 203 pathologically proven cases
G K Wenning, F Tison, Y Ben Shlomo, et al.
Presse Medicale (Paris, France : 1983)
|
November 18, 1995
[Encephalopathy in cat scratch disease]
F Tison, P Boulan, B Le Bail, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|
January 1, 1987
[Evaluation by biphotonic absorptiometry of bone mineral content and determination of the fracture threshold in a population of patients 60 to 75 years old]
B Duquesnoy, H Ythier, A Thévenon, et al.
Experimental Neurology
|
February 13, 2001
Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration
I Ghorayeb, Z Puschban, P O Fernagut, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 1, 2000
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration
I Ghorayeb, P O Fernagut, I Aubert, et al.
Journal of Neurology
|
February 1, 1996
Pain in multiple system atrophy
F Tison, G K Wenning, M A Volonte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 8, 2004
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy)
C Scherfler, T Sather, E Diguet, et al.
Neurology
|
January 11, 2007
Neurologic phenotypes associated with acanthocytosis
R H Walker, H H Jung, C Dobson-Stone, et al.
Synapse (New York, N.Y.)
|
November 19, 2013
Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy
P O Fernagut, W G Meissner, M Biran, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 3, 1999
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
E Bezard, C Brefel, F Tison, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 130) with videos related to
Sort By:
Page
of 13
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 1997
Multiple system atrophy: a review of 203 pathologically proven cases
G K Wenning, F Tison, Y Ben Shlomo, et al.
Presse Medicale (Paris, France : 1983)
|
November 18, 1995
[Encephalopathy in cat scratch disease]
F Tison, P Boulan, B Le Bail, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|
January 1, 1987
[Evaluation by biphotonic absorptiometry of bone mineral content and determination of the fracture threshold in a population of patients 60 to 75 years old]
B Duquesnoy, H Ythier, A Thévenon, et al.
Experimental Neurology
|
February 13, 2001
Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration
I Ghorayeb, Z Puschban, P O Fernagut, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 1, 2000
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration
I Ghorayeb, P O Fernagut, I Aubert, et al.
Journal of Neurology
|
February 1, 1996
Pain in multiple system atrophy
F Tison, G K Wenning, M A Volonte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 8, 2004
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy)
C Scherfler, T Sather, E Diguet, et al.
Neurology
|
January 11, 2007
Neurologic phenotypes associated with acanthocytosis
R H Walker, H H Jung, C Dobson-Stone, et al.
Synapse (New York, N.Y.)
|
November 19, 2013
Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy
P O Fernagut, W G Meissner, M Biran, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 3, 1999
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
E Bezard, C Brefel, F Tison, et al.
Page
of 13